Mathias Bressel

6PUBLICATIONS
46CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Information systems user experience design and development
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 26, 2026
Single-fraction or multi-fraction stereotactic ablative body radiotherapy followed by atezolizumab in advanced triple-negative breast cancer: a randomized phase II trial.

|Jul 08, 2026
Dynamic immune profiling predicts response to radiation plus anti-PD-1 therapy in oligometastatic renal cell carcinoma.

|Dec 11, 2025
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma.

Sasanka M Handunnetti, Amit Khot, Piers Blombery

|Apr 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissions.

Sasanka M Handunnetti, Mary Ann Anderson, Kate Burbury

|Jan 27, 2019
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing.

Louisa L Lo, Ian M Collins, Mathias Bressel

Pageof 1

Frequent Collaborators

3 joint publications

Paul Neeson

2 joint publications

Rodney John Hicks

2 joint publications

John F Seymour

2 joint publications

Stephen Lade